Agilon Health Inc (AGL): Next-Year EPS Estimate 43.25%
As of 2026-05-20, Agilon Health Inc (AGL) has a next-year EPS growth estimate of 43.25%. Featured in 7 EPS revision reports, most recently on 2026-05-20.
On 2026-05-19, analyst consensus for AGL's next-year EPS growth shifted from 37.33% to 43.25% — a positive change of 5.92 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at 88.47%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- EPS growth next year
- 43.25%
- EPS growth this year
- 88.47%
- EPS next quarter (est)
- $0.05
- Last price
- $80.94
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-20 | 43.25% | 88.47% | $0.05 | $80.94 |
| 2026-05-19 | 43.25% | 88.47% | $0.05 | $88.20 |
| 2026-05-18 | 37.33% | 87.37% | -$0.07 | $86.80 |
| 2026-05-17 | 31.39% | 86.64% | -$0.11 | $81.73 |
| 2026-05-14 | 28.37% | 85.24% | -$0.23 | $78.49 |
| 2026-05-13 | 27.31% | 84.84% | -$0.27 | $71.96 |
| 2026-05-12 | 27.31% | 84.84% | -$0.27 | $69.54 |
| 2026-05-11 | 27.31% | 84.84% | -$0.27 | $59.61 |
| 2026-05-06 | 26.33% | 78.03% | $1.04 | $27.85 |
| 2026-05-05 | 26.33% | 78.03% | $1.04 | $26.74 |
| 2026-05-04 | 26.32% | 78.03% | $1.04 | $26.94 |
| 2026-05-03 | 26.45% | 78.05% | $1.02 | $29.58 |
| 2026-04-30 | 26.45% | 78.05% | $1.02 | $27.95 |
| 2026-04-29 | 26.45% | 78.05% | $1.02 | $27.89 |
| 2026-04-28 | 26.45% | 78.05% | $1.02 | $27.90 |
| 2026-04-27 | 26.46% | 78.04% | $1.02 | $25.32 |
| 2026-04-26 | 26.46% | 78.04% | $1.02 | $26.21 |
| 2026-04-24 | 26.46% | 78.04% | $1.02 | $26.21 |
| 2026-04-23 | 26.46% | 78.04% | $1.02 | $26.32 |
| 2026-04-22 | 26.46% | 78.04% | $1.02 | $28.32 |
| 2026-04-14 | 25.34% | 76.66% | $1.27 | $22.68 |
| 2026-04-13 | 25.34% | 76.66% | $1.27 | $21.63 |
| 2026-04-12 | 25.34% | 76.66% | $1.27 | $19.02 |
| 2026-04-10 | 25.15% | 76.67% | $1.27 | $20.46 |
| 2026-04-09 | 25.14% | 76.67% | $1.27 | $19.84 |
Reports Featuring AGL
- 2026-05-20
AMPG, GCTS Lead EPS Revision Winners With 33-54% Gains This Week
- 2026-05-19
Healthcare Stocks Surge as LQDA, ERNA Lead EPS-Driven Rally
- 2026-05-18
Why ERNA, RDW, BRUN Led Gains After EPS Estimate Revisions
- 2026-05-14
AGL Jumps 194% as Healthcare Revisions Drive Top Performers
- 2026-05-13
AGL Rockets 169% as Healthcare Revisions Sweep Top Movers
- 2026-05-12
AGL Surges 160% After Earnings Beat; AMD, RIOT Lead Tech Rally
- 2026-05-11
Agilon Surges 123%: How EPS Revisions Triggered Mega-Cap Rally
Recent News
Screen Performance
Aggregate stats across all 1713 tickers our top-EPS-revision screen has flagged over the past 49 days.
- Median return since detection
- +2.8%
- % of tickers in the green
- 58%
- Median return on winners
- +15.1%
- Large revisions captured
- 630
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Agilon Health Inc's next-year EPS growth estimate?▾
As of 2026-05-20, Agilon Health Inc (AGL) has a next-year EPS growth estimate of 43.25%, based on analyst consensus.
When was the latest EPS estimate revision for AGL?▾
The most recent revision occurred on 2026-05-19, when analysts adjusted the next-year EPS growth estimate from 37.33% to 43.25%.
What sector and industry does Agilon Health Inc belong to?▾
Agilon Health Inc operates in the Healthcare sector, specifically the Medical Care Facilities industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AGL appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Agilon Health Inc (AGL) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports